Bacteria may be the next frontier in cancer treatment, according to a team led by researchers at Penn State that devised a new approach of creating bacteria-derived mixtures—or cocktails—to help fight bladder cancer.
Philips (NYSE: PHG)+ has announced the launch of what it calls the world’s first detector-based spectral CT fully powered by AI.
Medical Microinstruments (MMI) announced today that it won reimbursement for its surgical lymphovenous bypass (LVB) surgery system.
A team of scientists have developed a simple method for automated manufacturing of lung organoids which could revolutionize the development of treatments for lung disease. These organoids, miniature structures containing the cells that real lungs do, could be used to test early-stage experimental drugs more effectively, without needing to use animal material.
A new international study led by the Nanobiosystems group at CIC nanoGUNE, is developing miniature, non-invasive, precise robotic catheters for use in reproductive medicine and gynecological health.
Research led by the Veterans Affairs Portland Health Care System in Portland, Oregon, found that a single dose of respiratory syncytial virus (RSV) vaccine reduced RSV infections and RSV-related emergency visits, hospitalizations, and intensive care unit admissions among US veterans 60 years and older across two respiratory illness seasons. Protection was seen declining over time and falling most among immunocompromised individuals.
A team led by researchers from Penn State College of Medicine has developed a new method that substantially improves the ability to map the genetic variants that drive disease, particularly neurodegenerative diseases.
Electrotherapy using injectable nanoparticles delivered directly into the tumor could pave the way for new treatment options for glioblastoma, according to a new study from Lund University in Sweden.
Major technology breakthrough combines advanced AI for clinical insights and accelerated workflow in new premium 3.0T MRI platform
CLEVELAND, Dec. 1, 2025 /PRNewswire/ — MediView XR, Inc., a pioneer in clinical augmented reality and spatial computing, proudly announced its first CE mark certification, a significant regulatory milestone that enables the introduction of its innovative mixed reality solutions across Europe.